Patel, Viren

Patel, Viren was paid $1.53M by Medicaid between Jul 2019 and Nov 2024, across 129 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 20% of everything it billed.

Compared with peers

Next to other Anatomic Pathology & Clinical Pathology Physician providers in Pennsylvania

Rank by total paid#4 of 163

Median peer was paid$15K

This provider vs. median100×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2019	12,153	$74K
2020	29,507	$200K
2021	25,781	$313K
2022	41,928	$428K
2023	40,014	$330K
2024incomplete	32,638	$189K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	20%	5,454	4,395	$311K
88305	Level IV - Surgical pathology, gross and microscopic examination	6.8%	2,257	2,128	$104K
0202U	Oncology (prostate), multianalyte, gene expression profiling	6.2%	388	376	$95K
80053	Comprehensive metabolic panel	6.0%	18,198	15,027	$92K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	4.5%	3,174	3,055	$69K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	4.5%	3,168	3,051	$68K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	4.4%	23,816	18,107	$68K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	3.3%	1,085	1,011	$50K
84443	Thyroid stimulating hormone (TSH)	2.4%	4,629	4,339	$37K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	2.4%	933	842	$36K
0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	2.3%	468	435	$35K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	2.1%	1,332	1,144	$31K

117 more codes

88342		1.8%	1,468	$28K
87086	Culture, bacterial; quantitative colony count, urine	1.8%	5,513	$27K
80048	Basic metabolic panel (calcium, ionized)	1.6%	5,781	$24K
87480		1.5%	1,803	$23K
87510		1.5%	1,801	$23K
82803		1.4%	1,791	$21K
83735		1.3%	5,996	$21K
87660		1.0%	1,955	$16K
83605		1.0%	2,836	$15K
87040		<1%	1,588	$15K
82962		<1%	7,379	$14K
87081		<1%	4,545	$13K
84484		<1%	2,448	$12K
82330		<1%	1,379	$12K
80061	Lipid panel	<1%	3,244	$11K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	1,294	$10K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	710	$10K
85730		<1%	2,140	$9K
87641		<1%	433	$9K
87186		<1%	1,612	$9K
88307		<1%	150	$9K
83880		<1%	734	$8K
86780		<1%	955	$8K
83036	Hemoglobin; glycosylated (A1C)	<1%	2,395	$7K
85610		<1%	3,548	$7K
83690		<1%	2,086	$7K
81025		<1%	2,890	$7K
86850		<1%	2,203	$6K
80069		<1%	1,462	$6K
84100		<1%	2,742	$6K
82607		<1%	1,047	$6K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	275	$6K
81001		<1%	3,913	$5K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	214	$5K
86901		<1%	2,383	$5K
84439		<1%	1,170	$5K
86140		<1%	2,069	$5K
86803		<1%	621	$5K
82728		<1%	1,177	$5K
80202		<1%	639	$5K
86900		<1%	2,370	$4K
84466		<1%	928	$4K
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	235	$4K
88341		<1%	87	$4K
85384		<1%	1,069	$3K
87088		<1%	632	$3K
85379		<1%	813	$3K
82570		<1%	1,254	$3K
87147		<1%	1,804	$3K
82746		<1%	514	$3K
82784		<1%	387	$3K
85027		<1%	989	$3K
81003		<1%	2,573	$3K
84702		<1%	615	$3K
83540		<1%	875	$3K
87070		<1%	797	$3K
87340		<1%	396	$2K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	299	$2K
82550		<1%	718	$2K
83970		<1%	139	$2K
83615		<1%	704	$2K
85014		<1%	1,445	$2K
86003		<1%	58	$2K
80047		<1%	361	$2K
84703		<1%	441	$2K
85652		<1%	1,186	$1K
82565		<1%	596	$1K
86038		<1%	175	$1K
82043		<1%	655	$1K
83516		<1%	202	$1K
87205		<1%	576	$1K
86480		<1%	42	$1K
87581		<1%	73	$982.97
84550		<1%	460	$944.43
85018		<1%	640	$783.08
84146		<1%	126	$780.18
87536		<1%	18	$695.22
84478		<1%	279	$621.40
84156		<1%	540	$607.55
86920		<1%	122	$552.25
88304		<1%	30	$550.77
84295		<1%	189	$548.84
G0103	Prostate cancer screening; prostate specific antigen test (psa)	<1%	62	$545.60
84481		<1%	111	$535.08
86762		<1%	124	$530.63
85045		<1%	414	$506.25
82248		<1%	251	$495.14
82247		<1%	183	$487.76
80076		<1%	116	$449.05
84132		<1%	153	$357.50
82805		<1%	14	$329.82
82785		<1%	56	$281.00
86880		<1%	67	$279.75
82533		<1%	30	$275.11
87493		<1%	12	$274.92
83655		<1%	47	$263.91
82947		<1%	122	$231.15
86665		<1%	13	$231.10
82670		<1%	28	$218.61
85347		<1%	82	$208.29
80306		<1%	33	$197.64
87075		<1%	25	$178.93
86706		<1%	28	$156.04
87807		<1%	31	$155.93
80177		<1%	31	$144.25
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	13	$143.60
87184		<1%	31	$139.50
87341		<1%	15	$75.60
87210		<1%	21	$74.03
80164		<1%	15	$70.88
86308		<1%	31	$68.40
84480		<1%	14	$58.74
86592		<1%	18	$33.00
82950		<1%	13	$29.13
82009		<1%	14	$19.04
81015		<1%	18	$15.72
87077		0%	82	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.